tiprankstipranks
Trending News
More News >

bioAffinity Technologies Adjusts CEO Compensation Package

Story Highlights
bioAffinity Technologies Adjusts CEO Compensation Package

Confident Investing Starts Here:

bioAffinity Technologies, Inc. ( (BIAF) ) has issued an update.

On January 10, 2025, bioAffinity Technologies, Inc. announced that its Compensation Committee approved an amendment to increase the annual base salary of CEO Maria Zannes to $300,000, effective retroactively from November 1, 2024. This adjustment to the CEO’s compensation package reflects ongoing strategic decisions within the company that could have implications for its financial management and stakeholder relations.

More about bioAffinity Technologies, Inc.

YTD Price Performance: -19.79%

Average Trading Volume: 207,866

Technical Sentiment Consensus Rating: Buy

Learn more about BIAF stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App